Journal Information

Statistics

Follow this link to access the full text of the article

Original Article
Economic evaluation of ticagrelor for secondary prevention following acute coronary syndromes
Avaliação económica de ticagrelor em prevenção secundária pós Síndroma Coronário Agudo
Miguel Gouveiaa, Margarida Borgesb, Rosário Trindadec,
Corresponding author
, Klas Riknerd
a Católica Lisbon School of Business and Economics, Universidade Católica Portuguesa, Lisboa, Portugal
b Unidade de Farmacologia Clínica, Centro Hospitalar de Lisboa Central EPE & Laboratório de Farmacologia Clínica e Terapêutica, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal
c Corporate Affairs & Market Access Department, AstraZeneca - Produtos Farmacêuticos, Lda., Lisboa, Portugal
d Global Clinical Development Department, AstraZeneca, Mölndal, Sweden
Read
8056
Times
was read the article
1832
Total PDF
6224
Total HTML
Share statistics
Article information
ISSN: 21742049
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 May 1 2 3
2024 April 42 31 73
2024 March 42 19 61
2024 February 34 29 63
2024 January 24 26 50
2023 December 20 23 43
2023 November 27 27 54
2023 October 19 18 37
2023 September 21 16 37
2023 August 38 25 63
2023 July 18 9 27
2023 June 26 16 42
2023 May 34 29 63
2023 April 23 6 29
2023 March 35 18 53
2023 February 32 18 50
2023 January 29 17 46
2022 December 28 13 41
2022 November 34 28 62
2022 October 29 22 51
2022 September 25 26 51
2022 August 37 24 61
2022 July 30 24 54
2022 June 31 26 57
2022 May 31 27 58
2022 April 31 22 53
2022 March 24 34 58
2022 February 44 18 62
2022 January 59 23 82
2021 December 26 25 51
2021 November 127 32 159
2021 October 111 25 136
2021 September 45 37 82
2021 August 32 29 61
2021 July 35 30 65
2021 June 26 26 52
2021 May 34 25 59
2021 April 42 24 66
2021 March 54 15 69
2021 February 63 11 74
2021 January 28 14 42
2020 December 43 8 51
2020 November 24 11 35
2020 October 34 10 44
2020 September 64 4 68
2020 August 34 7 41
2020 July 59 10 69
2020 June 46 5 51
2020 May 41 12 53
2020 April 52 21 73
2020 March 50 10 60
2020 February 84 22 106
2020 January 38 14 52
2019 December 76 9 85
2019 November 30 12 42
2019 October 42 9 51
2019 September 57 7 64
2019 August 37 4 41
2019 July 44 14 58
2019 June 30 7 37
2019 May 37 15 52
2019 April 34 14 48
2019 March 59 9 68
2019 February 58 15 73
2019 January 61 8 69
2018 December 58 20 78
2018 November 258 23 281
2018 October 631 29 660
2018 September 157 14 171
2018 August 137 9 146
2018 July 67 6 73
2018 June 78 9 87
2018 May 59 13 72
2018 April 79 7 86
2018 March 111 4 115
2018 February 38 2 40
2018 January 32 5 37
2017 December 78 6 84
2017 November 40 6 46
2017 October 56 8 64
2017 September 37 5 42
2017 August 48 8 56
2017 July 51 13 64
2017 June 56 9 65
2017 May 53 8 61
2017 April 66 23 89
2017 March 68 29 97
2017 February 110 2 112
2017 January 56 2 58
2016 December 69 7 76
2016 November 44 3 47
2016 October 39 2 41
2016 September 28 7 35
2016 August 12 2 14
2016 July 15 3 18
2016 June 14 3 17
2016 May 12 2 14
2016 April 36 17 53
2016 March 65 31 96
2016 February 78 34 112
2016 January 92 34 126
2015 December 70 32 102
2015 November 78 22 100
2015 October 63 29 92
2015 September 55 23 78
2015 August 68 22 90
2015 July 45 13 58
2015 June 66 17 83
2015 May 47 11 58
2015 April 47 30 77
2015 March 39 18 57
2015 February 93 44 137
Show all

Follow this link to access the full text of the article

Idiomas
Revista Portuguesa de Cardiologia (English edition)
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

By checking that you are a health professional, you are stating that you are aware and accept that the Portuguese Journal of Cardiology (RPC) is the Data Controller that processes the personal information of users of its website, with its registered office at Campo Grande, n.º 28, 13.º, 1700-093 Lisbon, telephone 217 970 685 and 217 817 630, fax 217 931 095, and email revista@spc.pt. I declare for all purposes that the information provided herein is accurate and correct.